International Urology and Nephrology

, Volume 42, Issue 3, pp 741–752 | Cite as

Arterial stiffness in dialysis patients: where are we now?

  • Mehmet Kanbay
  • Baris Afsar
  • Paul Gusbeth-Tatomir
  • Adrian Covic
Nephrology - Review

Abstract

Patients with end-stage renal disease treated by chronic dialysis have an impressive mortality, which more than half of this mortality is attributable to cardiovascular disease. Despite stratification for sex, race, and the presence of diabetes, cardiovascular disease mortality is 10–30 times higher in dialysis patients compared to general population. In dialysis patients, both atherosclerosis (mainly affecting the intima of the arteries) and arteriosclerosis (affecting predominantly the media of large- and middle-sized arteries diffusely) are highly prominent. Arteriosclerosis characterized by reduced arterial compliance (i.e., reduced elasticity of the arteries) is due to increased fibrosis, loss of elastic fibers, and extensive vessel wall calcification. Arteriosclerosis is closely related to arterial stiffness. A generally accepted mechanistic view is that an increase in arterial stiffness causes a premature return of reflected waves in late systole, increasing central pulse pressure, thus systolic. An increased arterial stiffness can increase the risk of stroke through several mechanisms, including an increase in central pulse pressure, influencing arterial remodeling both at the site of the extracranial and intracranial arteries, increasing carotid wall thickness, and the development of stenosis and plaques, and the likelihood of plaque rupture. Very importantly, it was also suggested that arterial stiffness itself independently plays a role in exacerbating chronic kidney disease progression. This review deals briefly with the definition of arterial stiffness, methods of measuring arterial stiffness and pathophysiology of arterial stiffness, and factors related with arterial stiffness.

Keywords

Arterial stiffness Chronic kidney disease 

References

  1. 1.
    Foley RN, Parfrey PS, Sarnak MJ (1998) Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 32:S112–S119CrossRefPubMedGoogle Scholar
  2. 2.
    Gusbeth-Tatomir P, Covic A (2007) Causes and consequences of increased arterial stiffness in chronic kidney disease patients. Kidney Blood Press Res 30:97–107CrossRefPubMedGoogle Scholar
  3. 3.
    Covic A, Gusbeth-Tatomir P, Goldsmith DJ (2005) Arterial stiffness in renal patients: an update. Am J Kidney Dis 45:965–977CrossRefPubMedGoogle Scholar
  4. 4.
    Laurent S et al (2006) Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 27:2588–2605CrossRefPubMedGoogle Scholar
  5. 5.
    Boutouyrie P, Bussy C, Hayoz D, Hengstler J, Dartois N, Laloux B, Brunner H, Laurent S (2000) Local pulse pressure and regression of arterial wall hypertrophy during long term antihypertensive treatment. Circulation 101:2601–2606PubMedGoogle Scholar
  6. 6.
    Zureik M, Ducimetiere P, Touboul PJ, Courbon D, Bonithon-Kopp C, Berr C, Magne C (2000) Common carotid intima-media thickness predicts occurrence of carotid atherosclerotic plaques longitudinal results from the ageing vascular study (EVA) study. Arterioscler Thromb Vasc Biol 20:1622–1629PubMedGoogle Scholar
  7. 7.
    Cheng GC, Loree HM, Kamm RD, Fishbein MC, Lee RT (1993) Distribution of circumferential stress in ruptured and stable atherosclerotic lesions: a structural analysis with histopathological correlation. Circulation 87:1179–1187PubMedGoogle Scholar
  8. 8.
    Taal MW, Sigrist MK, Fakis A, Fluck RJ, McIntyre CW (2007) Markers of arterial stiffness are risk factors for progression to end-stage renal disease among patients with chronic kidney disease stages 4 and 5. Nephron Clin Pract 107:c177–c181Google Scholar
  9. 9.
    Zoungas S, Asmar RP (2007) Arterial stiffness and cardiovascular outcome. Clin Exp Pharmacol Physiol 34:647–651CrossRefPubMedGoogle Scholar
  10. 10.
    Celermajer DS (1998) Noninvasive detection of atherosclerosis. N Engl J Med 339:2014–2015CrossRefPubMedGoogle Scholar
  11. 11.
    Asmar R, Benetos A, Topouchian J, Laurent P, Pannier B, Brisac AM, Target R, Levy BI (1995) Assessment of arterial distensibility by automatic pulse wave velocity measurement. Validation and clinical application studies. Hypertension 26:485–490PubMedGoogle Scholar
  12. 12.
    Van Bortel LM, Duprez D, Starmans-Kool MJ, Safar ME, Giannattasio C, Cockcroft J, Kaiser DR, Thuillez C (2002) Applications of arterial stiffness, Task Force III: recommendations for user procedures. Am J Hypertens 15:445–452CrossRefPubMedGoogle Scholar
  13. 13.
    McEniery CM, Yasmin HallIR, Qasem A, Wilkinson IB, Cockcroft JR (2005) Normal vascular aging: differential effects on wave reflection and aortic pulse wave velocity: the Anglo-Cardiff Collaborative Trial (ACCT). J Am Coll Cardiol 46:1753–1760CrossRefPubMedGoogle Scholar
  14. 14.
    Nichols WW, O’Rourke MF (1998) Vascular impedance. In: Nichols WW, O’Rourke MF (ed) McDonald’s blood flow in arteries: theoretical, experimental and clinical principles. 4th edn. London: Edward Arnold, pp 54–97, 243–283, 347–395Google Scholar
  15. 15.
    Ratto E, Leoncini G, Viazzi F, Vaccaro V, Falqui V, Parodi A, Conti N, Tomolillo C, Deferrari G, Pontremoli R (2006) Ambulatory arterial stiffness index and renal abnormalities in primary hypertension. J Hypertens 24:2033–2038CrossRefPubMedGoogle Scholar
  16. 16.
    Schillaci G, Parati G, Pirro M, Pucci G, Mannarino MR, Sperandini L, Mannarino E (2007) Ambulatory arterial stiffness ındex ıs not a specific marker of reduced arterial compliance. Hypertension 49:986–991CrossRefPubMedGoogle Scholar
  17. 17.
    Vogel RA, Benitez RM (2000) Noninvasive assessment of cardiovascular risk: from Framingham to the future. Rev Cardiovasc Med 1:34–42PubMedGoogle Scholar
  18. 18.
    Komai N, Ohishi M, Morishita R, Moriguchi A, Kaibe M, Matsumoto K, Rakugi H, Higaki J, Ogihara T (2002) Arterial stiffness index: a new evaluation for arterial stiffness in elderly patients with essential hypertension. Geriatric Geront Int 15:199–205Google Scholar
  19. 19.
    Hiramatsu K, Oiwa A, Shigematsu S et al (2004) A novel arterial stiffness index (ASI) as a marker of arteriosclerosis. Am J Hypertens 17:131ACrossRefGoogle Scholar
  20. 20.
    Kocak H, Gumuslu S, Sahin E, Ceken K, Ermis C, Gocmen AY, Yakupoglu G, Ersoy FF, Suleymanlar G, Tuncer M (2009) Relationship between carotid artery intima-media thickness and brachial artery flow-mediated dilation in peritoneal dialysis patients. Int Urol Nephrol 41(2):409–416CrossRefPubMedGoogle Scholar
  21. 21.
    Adragão T, Pires A, Birne R, Curto JD, Lucas C, Gonçalves M, Negrão AP (2009) A plain X-ray vascular calcification score is associated with arterial stiffness and mortality in dialysis patients. Nephrol Dial Transplant 24(3):997–1002CrossRefPubMedGoogle Scholar
  22. 22.
    Mark PB, Doyle A, Blyth KG, Patel RK, Weir RA, Steedman T, Foster JE, Dargie HJ, Jardine AG (2008) Vascular function assessed with cardiovascular magnetic resonance predicts survival in patients with advanced chronic kidney disease. J Cardiovasc Magn Reson 10(1):39CrossRefPubMedGoogle Scholar
  23. 23.
    London GM, Marchais SJ, Guerin AP, Metivier F (2002) Impairment of arterial function in chronic renal disease: prognostic impact and therapeutic approach. Nephrol Dial Transplant 12:13–15Google Scholar
  24. 24.
    Mourad JJ, Pannier B, Blacher J et al (2001) Creatinine clearance, pulse wave velocity, carotid compliance and essential hypertension. Kidney Int 59:1834–1841CrossRefPubMedGoogle Scholar
  25. 25.
    Benetos A, Adamopoulos C, Bureau JM et al (2002) Determinants of accelerated progression of arterial stiffness in normotensive subjects and in treated hypertensive subjects over a 6-year period. Circulation 105:1202–1207CrossRefPubMedGoogle Scholar
  26. 26.
    Makita Z, Bucala R, Rayfield EJ, Friedman EA, Kaufman AM, Korbet SM, Barth RH, Winston JA, Fuh H, Manogue KR et al (1994) Reactive glycosylation end-products in diabetic uremia and treatment of renal failure. Lancet 343:1519–1522CrossRefPubMedGoogle Scholar
  27. 27.
    Miyata T, de Strihou C, Kurokawa K, Baynes JW (1999) Alterations in nonenzymatic biochemistry in uremia: origin and significance of ‘carbonyl stress’ in long-term uremic complications. Kidney Int 55:389–399CrossRefPubMedGoogle Scholar
  28. 28.
    Tycho Vuurmans JL, Boer WH, Bos WJ, Blankestijn PJ, Koomans HA (2002) Contribution of volume overload and angiotensin II to the increase pulse wave velocity of hemodialysis patients. J Am Soc Nephrol 13:177–183PubMedGoogle Scholar
  29. 29.
    Lin YP, Yu WC, Hsu TL, Ding PY, Yang WC, Chen CH (2003) The extracellular fluid-to-intracellular fluid volume ratio is associated with large-artery structure and function in hemodialysis patients. Am J Kidney Dis 42:990–999CrossRefPubMedGoogle Scholar
  30. 30.
    Kobayashi S, Okamoto K, Maesato K, Moriya H, Ohtake T (2005) Important role of blood rheology in atherosclerosis of patients with hemodialysis. Hemodial Int 9:268–274CrossRefPubMedGoogle Scholar
  31. 31.
    Cheng LT, Tang LJ, Chen HM, Tang W, Wang T (2008) Relationship between serum albumin and pulse wave velocity in patients on continuous ambulatory peritoneal dialysis. Vasc Health Risk Manag 4(4):871–876PubMedGoogle Scholar
  32. 32.
    London GM, Marchais SJ, Safar ME, Genest AF, Guerin AP, Metivier F, Chedid K, London AM (1990) Aortic and large artery compliance in end-stage renal failure. Kidney Int 37:137–142CrossRefPubMedGoogle Scholar
  33. 33.
    Nakamura T, Kawagoe Y, Matsuda T, Takahashi Y, Sekizuka K, Ebihara I, Koide H (2003) Effects of LDL apheresis and vitamin E-modified membrane on carotid atherosclerosis in hemodialyzed patients with arteriosclerosis obliterans. Kidney Blood Press Res 26:185–191CrossRefPubMedGoogle Scholar
  34. 34.
    Moe SM, Reslerova M, Ketteler M, O’Neill K, Duan D, Koczman J, Westenfeld R, Jahnen-Dechent W, Chen NX (2005) Role of calcification inhibitors in the pathogenesis of vascular calcification in chronic kidney disease. Kidney Int 67:2295–2304CrossRefPubMedGoogle Scholar
  35. 35.
    Wang AY, Woo J, Lam CW, Wang M, Chan IH, Gao P, Lui SF, Li PK, Sanderson JE (2005) Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients. Nephrol DialTransplant 20:1676–1685Google Scholar
  36. 36.
    Cozzolino M, Brancaccio D, Gallieni M, Slatopolsky E (2005) Pathogenesis of vascular calcification in chronic kidney disease. Kidney Int 68:429–436CrossRefPubMedGoogle Scholar
  37. 37.
    Goldsmith DJ, Covic A, Sambrook PA, Ackrill P (1997) Vascular calcification in long-term hemodialysis patients in a single unit: a retrospective analysis. Nephron 77:37–43CrossRefPubMedGoogle Scholar
  38. 38.
    Reynolds JL, Joannides AJ, Skepper JN, Mc-Nair R, Schurgers LJ, Proudfoot D, Jahnen-Dechent W, Weissberg PL, Shanahan CM (2004) Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD. J Am Soc Nephrol 15:2857–2867CrossRefPubMedGoogle Scholar
  39. 39.
    Tintut Y, Patel J, Territo M, Saini T, Parhami F, Demer LL (2002) Monocyte/macrophage regulation of vascular calcification in vitro. Circulation 105:650–655CrossRefPubMedGoogle Scholar
  40. 40.
    Tintut Y, Patel J, Parhami F, Demer LL (2000) Tumor necrosis factor- alpha promotes in vitro calcification of vascular cells via the cAMP pathway. Circulation 102:2636–2642PubMedGoogle Scholar
  41. 41.
    Wang AY, Woo J, Wang M, Sea MM, Ip R, Li PK, Lui SF, Sanderson JE (2001) Association of inflammation and malnutrition with cardiac valve calcification in continuous ambulatory peritoneal dialysis patients. J Am Soc Nephrol 12:1927–1936PubMedGoogle Scholar
  42. 42.
    Haydar AA, Hujairi NM, Covic AA, Pereira D, Rubens M, Goldsmith DJ (2004) Coronary artery calcification is related to coronary atherosclerosis in chronic renal disease patients: a study comparing EBCT-generated coronary artery calcium scores and coronary angiography. Nephrol Dial Transplant 19:2307–2312CrossRefPubMedGoogle Scholar
  43. 43.
    Kullo IJ, Bielak LF, Turner ST, Sheedy PF 2nd, Peyser PA (2006) Aortic pulse wave velocity is associated with the presence and quantity of coronary artery calcium. A communitybased study. Hypertension 47:174–179CrossRefPubMedGoogle Scholar
  44. 44.
    Guérin AP, London GM, Marchais SJ, Metivier F (2000) Arterialstiffening and vascular calcifications in end-stage renal disease. Nephrol Dial Transplant 15:1014–1021CrossRefPubMedGoogle Scholar
  45. 45.
    London GM, Blacher J, Pannier B, Guérin AP, Marchais SJ, Safar ME (2001) Impact of aortic stiffness attenuation on survival of patients in endstage renal failure. Circulation 103:987–992PubMedGoogle Scholar
  46. 46.
    Blacher J, Guerin AP, Pannier B, Marchais SJ, London GM (2001) Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 38:938–942CrossRefPubMedGoogle Scholar
  47. 47.
    Fang W, Yang X, Bargman JM, Oreopoulos DG (2009) Association between pulse pressure and mortality in patients undergoing peritoneal dialysis. Perit Dial Int 29(2):163–170PubMedGoogle Scholar
  48. 48.
    Ogawa T, Shimada M, Ishida H, Matsuda N, Fujiu A, Ando Y, Nitta K (2009) Relation of stiffness parameter beta to carotid arteriosclerosis and silent cerebral infarction in patients on chronic hemodialysis. Int Urol Nephrol 41(3):739–745CrossRefPubMedGoogle Scholar
  49. 49.
    Haydar AA, Covic A, Colhoun H, Rubens M, Goldsmith DJ (2004) Coronary artery calcification and aortic pulse wave velocity in chronic kidney disease patients. Kidney Int 65:1790–1794CrossRefPubMedGoogle Scholar
  50. 50.
    London GM, Marchais SJ, Guérin AP, Boutouyrie P, Métivier F, de Vernejoul MC (2008) Association of bone activity, calcium load, aortic stiffness, and calcifications in ESRD. J Am Soc Nephrol 19:1827–1835CrossRefPubMedGoogle Scholar
  51. 51.
    Bossola M, Muscaritoli M, Tazza L, Giungi S, Tortorelli A, Rossi Fanelli F, Luciani G (2005) Malnutrition in hemodialysis patients: what therapy? Am J Kidney Dis 46:371–386CrossRefPubMedGoogle Scholar
  52. 52.
    Gu Yue, Cheng Li-Tao, Chen Hui-Min, Sun Xiao-Yan, Tang Li-Jun, Guo Li-Juan, Axelsson Jonas, Wang Tao (2008) Strong association between nutritional markers and arterial stiffness in continuous ambulatory peritoneal dialysis patients. Blood Purif 26:340–346CrossRefPubMedGoogle Scholar
  53. 53.
    Schafer C, Heiss A, Schwarz A et al (2003) The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest 112:357–366PubMedGoogle Scholar
  54. 54.
    Jahnen-Dechent W, Schinke T, Trindl A, Müller-Esterl W, Sablitzky F, Kaiser S, Blessing M (1997) Cloning and targeted deletion of the mouse fetuin gene. J Biol Chem 272:31496–31503CrossRefPubMedGoogle Scholar
  55. 55.
    Moe SM, Chen NX (2005) Inflammation and vascular calcification. Blood Purif 23:64–71CrossRefPubMedGoogle Scholar
  56. 56.
    Hermans MM, Brandenburg V, Ketteler M, Kooman JP, van der Sande FM, Gladziwa U, Rensma PL, Bartelet K, Konings CJ, Hoeks AP, Floege J, Leunissen KM (2006) Study on the relationship of serum fetuin-A concentration with aortic stiffness in patients on dialysis. Nephrol Dial Transplant 21:1293–1299CrossRefPubMedGoogle Scholar
  57. 57.
    Sigrist MhairiK, Taal MaartenW, Bungay Peter, Christopher W (2007) McIntyre progressive vascular calcification over 2 years ıs associated with arterial stiffening and ıncreased mortality in patients with stages 4 and 5 chronic kidney disease. Clin J Am Soc Nephrol 2:1241–1248CrossRefPubMedGoogle Scholar
  58. 58.
    Chesterton LJ, Sigrist MK, Bennett T, Taal MW, McIntyre CW (2005) Reduced baroreflex sensitivity is associated with increased vascular calcification and arterial stiffness. Nephrol Dial Transplant 20:1140–1147CrossRefPubMedGoogle Scholar
  59. 59.
    Hermans MM, Vermeer C, Kooman JP, Brandenburg V, Ketteler M, Gladziwa U, Rensma PL, Leunissen KM, Schurgers LJ (2007) Undercarboxylated matrix GLA protein levels are decreased in dialysis patients and related to parameters of calcium-phosphate metabolism and aortic augmentation ındex. Blood Purif 25:395–401CrossRefPubMedGoogle Scholar
  60. 60.
    Wilkinson IB, Franklin SS, Cockcroft JR (2004) Nitric oxide and the regulation of large artery stiffness: from physiology to pharmacology. Hypertension 44:112–116CrossRefPubMedGoogle Scholar
  61. 61.
    Kielstein JT, Böger RH, Bode-Böger SM, Schäffer J, Barbey M, Koch KM, Frölich JC (1999) Asymmetric dimethylarginine plasma concentrations differ in patients with endstage renal disease: Relationship to treatment method and atherosclerotic disease. J Am Soc Nephrol 10:594–600PubMedGoogle Scholar
  62. 62.
    Mardare NG, Goldsmith DJ, Gusbeth-Tatomir P, Covic A (2005) Intradialytic changes in reflective properties of the arterial system during a single hemodialysis session. Hemodial Int 9:376–382CrossRefPubMedGoogle Scholar
  63. 63.
    Wikström IngaSoveriLarsLindBjörn, Zilmer Mihkel, Zilmer Kersti, Fellström Bengt (2007) Improvement in central arterial pressure waveform during hemodialysis ıs related to a reduction in asymmetric dimethylarginine (ADMA) levels. Nephron Clin Pract 106:c180–c186CrossRefPubMedGoogle Scholar
  64. 64.
    Blacher J, Demuth K, Guerin AP, Safar ME, Moatti N, London GM (1998) Influence of biochemical alterations on arterial stiffness in patients with end-stage renal disease. Arterioscler Thromb Vasc Biol 18:535–541PubMedGoogle Scholar
  65. 65.
    van Guldener C, Lambert J, ter Wee PM, Donker AJ, Stehouwer CD (2000) Carotid artery stiffness in patients with end-stage renal disease: no effect of long-term homocysteine-lowering therapy. Clin Nephrol 53:33–41PubMedGoogle Scholar
  66. 66.
    Tsai JC, Kuo HT, Chiu YW, Hwang SJ, Chuang HY, Chang JM, Chen HC, Lai YH (2005) Correlation of plasma homocysteine level with arterial stiffness and pulse pressure in hemodialysis patients. Atherosclerosis 182:121–127CrossRefPubMedGoogle Scholar
  67. 67.
    London GM, Guerin AP, Verbeke FH, Pannier B, Boutouyrie P, Marchais SJ, Metivier F (2007) Mineral metabolism and arterial functions in end-stage renal disease: potential role of 25-hydroxyvitamin D deficiency. J Am Soc Nephrol 18:369–373CrossRefGoogle Scholar
  68. 68.
    Raggi P, Bellasi A, Ferramosca E, Block GA, Muntner P (2007) Pulse wave velocity is inversely related to vertebral bone density in hemodialysis patients. Hypertension 49:1278–1284CrossRefPubMedGoogle Scholar
  69. 69.
    Toussaint ND, Lau KK, Strauss BJ, Polkinghorne KR, Kerr PG (2008) Associations between vascular calcification, arterial stiffness and bonemineral density in chronic kidney disease. Nephrol Dial Transplant 23(2):586–593CrossRefPubMedGoogle Scholar
  70. 70.
    Shimada T, Hasegawa H, Yamazaki Y, Muto T, Hino R, Takeuchi Y, Fujita T, Nakahara K, Fukumoto S, Yamashita T (2004) FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res 19:429–435CrossRefPubMedGoogle Scholar
  71. 71.
    Shimada T, Mizutani S, Muto T, Yoneya T, Hino R, Takeda S, Takeuchi Y, Fujita T, Fukumoto S, Yamashita T (2001) Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc Natl Acad Sci USA 98:6500–6505CrossRefPubMedGoogle Scholar
  72. 72.
    Larsson T, Nisbeth U, Ljunggren O, Juppner H, Jonsson KB (2003) Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers. Kidney Int 64(6):2272–2279CrossRefPubMedGoogle Scholar
  73. 73.
    Gutiérrez OM, Mannstadt M, Isakova T, Rauh-Hain JA, Tamez H, Shah A, Smith K, Lee H, Thadhani R, Jüppner H, Wolf M (2008) Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med 359:584–592CrossRefPubMedGoogle Scholar
  74. 74.
    Mirza MA, Larsson A, Lind L, Larsson TE (2009) Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community. Atherosclerosis 205:385–390Google Scholar
  75. 75.
    Tzanakis IP, Oreopoulos DG (2009) Beneficial effects of magnesium in chronic renal failure: a foe no longer. Int Urol Nephrol 41(2):363–371CrossRefPubMedGoogle Scholar
  76. 76.
    Turgut F, Kanbay M, Metin MR, Uz E, Akcay A, Covic A (2008) Magnesium supplementation helps to improve carotid intima media thickness in patients on hemodialysis. Int Urol Nephrol 40(4):1075–1082CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, B.V. 2009

Authors and Affiliations

  • Mehmet Kanbay
    • 1
  • Baris Afsar
    • 1
  • Paul Gusbeth-Tatomir
    • 2
  • Adrian Covic
    • 2
  1. 1.Department of Internal Medicine, Section of NephrologyFatih University School of MedicineCevizlidere/Cankaya, AnkaraTurkey
  2. 2.Department of Nephrology Clinic and Dialysis and Transplantation Center“C. I. PARHON” University HospitalIasiRomania

Personalised recommendations